COVID-19: An Overview of SARS-CoV-2 Variants-The Current Vaccines and Drug Development.

Bostanghadiri, Narjess; Ziaeefar, Pardis; Mofrad, Morvarid Golrokh; Yousefzadeh, Parsa; Hashemi, Ali; Darban-Sarokhalil, Davood

Bostanghadiri, Narjess; Ziaeefar, Pardis; Mofrad, Morvarid Golrokh; Yousefzadeh, Parsa; Hashemi, Ali; Darban-Sarokhalil, Davood.

Afiliação

Bostanghadiri N; Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Ziaeefar P; School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mofrad MG; Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran.
Yousefzadeh P; School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Hashemi A; Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Darban-Sarokhalil D; Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Biomed Res Int ; 2023: 1879554, 2023.

Article em En | MEDLINE | ID: mdl-37674935

Assuntos

COVID-19; Vacinas; Estados Unidos; Humanos; SARS-CoV-2; COVID-19/prevenção & controle; Pandemias/prevenção & controle; Desenvolvimento de Medicamentos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google